https://aspatients.org/surveillor/ 2026-04-17T08:31:37+00:00 https://aspatients.org/surveillor/time-to-rage-against-the-prostate-cancer-machine/ 2023-03-20T18:43:00+00:00 https://aspatients.org/surveillor/must-read-for-potential-active-surveillors-new-edition-of-the-invasion-of-the-prostate-snatchers/ 2023-03-22T10:52:14+00:00 https://aspatients.org/surveillor/moving-the-needle-on-as-michigan-shows-a-path-to-a-90-as-rate/ 2023-03-22T10:52:24+00:00 https://aspatients.org/surveillor/ass-dirty-little-secret-the-dropout-rate/ 2023-03-22T10:52:29+00:00 https://aspatients.org/surveillor/active-surveillance-hits-60-in-the-u-s-but-lags-far-behind-canada-holland-and-sweden/ 2023-03-22T10:52:33+00:00 https://aspatients.org/surveillor/dr-william-li-presents-to-aspi-of-lycopene-tangerine-tomatoes-angiogenesis-and-lots-more/ 2023-03-22T10:53:17+00:00 https://aspatients.org/surveillor/if-gleason-6-were-redefined-as-noncancer-only-5-of-patients-say-they-would-quit-surveillance-82-would-stick-with-program/ 2023-03-22T10:53:25+00:00 https://aspatients.org/surveillor/why-news-coverage-of-prostate-cancer-and-as-usually-not-always-sucks/ 2023-03-22T10:53:32+00:00 https://aspatients.org/surveillor/a-cancer-on-the-senate-and-the-political-media/ 2023-03-22T10:53:36+00:00 https://aspatients.org/surveillor/patient-beware-urologists-more-biased-than-rad-oncs-in-2nd-opinions/ 2023-03-22T10:54:28+00:00 https://aspatients.org/surveillor/active-surveillance-for-low-risk-prostate-cancer-why-cant-america-be-more-like-sweden/ 2023-03-22T10:54:56+00:00 https://aspatients.org/surveillor/isopsa-cuts-biopsy-rate-in-half-for-newbies/ 2023-03-22T10:55:03+00:00 https://aspatients.org/surveillor/this-just-in-eggener-gupta-catalona-and-theactivesurveillor-launch-the-debate-on-renaming-gleason-6/ 2023-03-22T10:55:08+00:00 https://aspatients.org/surveillor/the-persistent-mythology-of-urology-urinary-symptoms-and-most-prostate-cancers/ 2023-03-22T10:55:54+00:00 https://aspatients.org/surveillor/dr-ai-prostate-cancer-more/ 2023-05-03T13:39:16+00:00 https://aspatients.org/surveillor/whos-on-right-side-of-history-in-ongoing-debate-over-whether-gleason-6-is-really-a-cancer/ 2023-05-03T13:43:23+00:00 https://aspatients.org/surveillor/prostate-cancer-patients-and-other-wildlife-along-the-road-less-traveled/ 2023-05-03T14:01:49+00:00 https://aspatients.org/surveillor/breaking-news-german-study-gives-finger-to-digital-rectal-exam/ 2023-08-24T15:18:46+00:00 https://aspatients.org/surveillor/more-breaking-news-from-eau-protect-study-offers-some-new-angles-on-impotence-incontinence-in-active-monitoring-patients/ 2023-08-24T15:22:47+00:00 https://aspatients.org/surveillor/this-just-in-can-a-new-mri-technique-reduce-biopsies-by-90/ 2023-08-24T15:34:53+00:00 https://aspatients.org/surveillor/isopsa-cuts-biopsy-rate-in-half-for-newbies-2/ 2023-08-24T15:36:36+00:00 https://aspatients.org/surveillor/new-study-shows-strong-support-for-re-labeling-gleason-6-growths-as-noncancers/ 2023-08-24T15:40:29+00:00 https://aspatients.org/surveillor/the-real-face-of-mens-health/ 2026-04-17T08:31:37+00:00